Phytochemistry and Pharmacological Activities of Vernonia amygdalina

Sagar Laxman Pol; Pratima Singh; Mihir Otia; Sunil Kothari; Shubham K Mohata; Jay Prakash

doi:10.55544/jrasb.3.3.22

Authors

Sagar Laxman Pol Assistant professor, Bharati Vidyapeeth Institute of Pharmacy, CBD Belapur, Navi Mumbai, INDIA.
Pratima Singh Department of Pharmaceutical Chemistry, Swami Vivekanand College of Pharmacy, Indore, INDIA.
Mihir Otia M. Pharm, MBA University of East London, UNITED KINGDOM.
Sunil Kothari Associate Professor, Surajmal College of Pharmacy, Surajmal University Kichha, INDIA.
Shubham K. Mohata Lecturer, New Montfort Institute of Pharmacy Ashti, Wardha Maharashtra-442202, INDIA.
Jay Prakash Clinical Pharmacologist, Paras Health Gurugram, INDIA.

DOI:

https://doi.org/10.55544/jrasb.3.3.22

Keywords:

Vernonia amygdalina, Phytochemistry, Pharmacological activities, Bitter leaf

Abstract

Vernonia amygdalina is a small tree that can grow to a height of ten metres. It is sometimes referred to as bitter leaf due to the fact that its leaves have a bitter bitter flavour and its branches are frail. Although its natural habitat is in tropical Africa, it may be found all over the world in regions that receive an average rainfall of 750–2000 millimetres. These regions include areas that are adjacent to rivers and lakes, as well as forests and grasslands that are located up to an elevation of 2800 metres. The plant is mostly employed as a medicinal herb in the context of traditional medical practices. The plant contains a variety of phytoconstituents, the most important of which are phenol, oxalate, phytates, tannins, flavonoids, cyanogenic glycosides, alkaloids, terpenes, anthraquinone, steroids, coumarins, lignans, xanthones, edotides, sesquiterpenes, and phenol. There are a number of advantages associated with this plant, including its capacity to alleviate fever and pain, as well as its antidiabetic, anti-inflammatory, antioxidant, chemoprotective, and cytotoxic activities.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Igile, G. O., Oleszek, W., Burda, S., & Jurzysta, M. (1995). Nutritional assessment of Vernonia amygdalina leaves in growing mice. Journal of Agricultural and Food Chemistry, 43(8), 2162-2166.

Ojiako, O. A. Nwanjo. 2006. Is Vernonia Amygdalina Hepatotoxic or Hepatoprotective? Response From Biochemical and Toxicity Studies in Rats. African Journal of Biotechnology, 1648-1651.

Erasto, P., Grierson, D. S., & Afolayan, A. J. (2006). Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. Journal of ethnopharmacology, 106(1), 117-120.

Bonsi, M. L. K., Osuji, P. O., Tuah, A. K., & Umunna, N. N. (1995). Vernonia amygdalina as a supplement to teff straw (Eragrostis tef) fed to Ethiopian Menz sheep. Agroforestry systems, 31, 229-241.

Huffman, M. A., & Seifu, M. (1989). Observations on the illness and consumption of a possibly medicinal plant Vernonia amygdalina (Del.), by a wild chimpanzee in the Mahale Mountains National Park, Tanzania. Primates, 30, 51-63.

Huffman, M. A. (2001). Self-Medicative Behavior in the African Great Apes: An Evolutionary Perspective into the Origins of Human Traditional Medicine: In addition to giving us a deeper understanding of our closest living relatives, the study of great ape self-medication provides a window into the origins of herbal medicine use by humans and promises to provide new insights into ways of treating parasite infections and other serious diseases. BioScience, 51(8), 651-661.

Huffman, M. A. (2003). Animal self-medication and ethno-medicine: exploration and exploitation of the medicinal properties of plants. Proceedings of the Nutrition Society, 62(2), 371-381.

Barnes, P., Yeboah, J. K., Gbedema, W., Saahene, R. O., & Amoani, B. (2020). Ameliorative Effect of Vernonia amygdalina Plant Extract on Heavy Metal‐Induced Liver and Kidney Dysfunction in Rats. Advances in Pharmacological and Pharmaceutical Sciences, 2020(1), 2976905.

Farombi, E. O., & Owoeye, O. (2011). Antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoid. International journal of environmental research and public health, 8(6), 2533-2555.

Ijeh, I. I., & Ejike, C. E. C. C. (2011). Current perspectives on the medicinal potentials of Vernonia amygdalina Del. Journal of medicinal plants research, 5(7), 1051-1061.

Mohammed, A., Kumar, D., & Rizvi, S. I. (2015). Antidiabetic potential of some less commonly used plants in traditional medicinal systems of India and Nigeria. Journal of Intercultural Ethnopharmacology, 4(1), 78.

Yedjou, C., Izevbigie, E., & Tchounwou, P. (2008). Preclinical assessment of Vernonia amygdalina leaf extracts as DNA damaging anti-cancer agent in the management of breast cancer. International Journal of Environmental Research and Public Health, 5(5), 337-341.

Joseph, J., Khor, K. Z., Moses, E. J., Lim, V., Aziz, M. Y., & Abdul Samad, N. (2021). In vitro anticancer effects of Vernonia amygdalina leaf extract and green-synthesised silver nanoparticles. International journal of nanomedicine, 3599-3612.

Ohigashi, H., Jisaka, M., Takagaki, T., Nozaki, H., Tada, T., Huffman, M. A., ... & Koshimizu, K. (1991). Bitter principle and a related steroid glucoside from Vernonia amygdalina, a possible medicinal plant for wild chimpanzees. Agricultural and Biological Chemistry, 55(4), 1201-1203.

Singha, S. C. (1965). Medicinal plants of Nigeria. Nigerian National Press.

Dalziel, J. M. (1937). The useful plants of west tropical Africa. The Useful Plants of West Tropical Africa.

Getahun, A. (1976). Some common medicinal and poisonous plants used in Ethiopian folk medicine.

Oliver, B. E. P. (1960). Medicinal plants in Nigeria. Nigerian College of arts. Science and Technology, 21(37), 52-53.

Masaba, S. C. (2000). The antimalarial activity of Vernonia amygdalina Del (Compositae).

Degu, S., Meresa, A., Animaw, Z., Jegnie, M., Asfaw, A., & Tegegn, G. (2024). Vernonia amygdalina: a comprehensive review of the nutritional makeup, traditional medicinal use, and pharmacology of isolated phytochemicals and compounds. Frontiers in Natural Products, 3, 1347855.

Okolie, H., Ndukwe, O., Obidiebube, E., Obasi, C., & Enwerem, J. (2021). Evaluation of Nutritional and Phytochemical Compositions of Two bitter Leaf (Vernonia amygdalina) Accessions in Nigeria. International Journal of Research and Innovation in Applied Science, 6(12), 16-20.

Paul, T. A., Taibat, I., Kenneth, E. I., Haruna, N. I., Baba, O. V., & Helma, A. R. (2018). Phytochemical and antibacterial analysis of aqueous and alcoholic extracts of Vernonia amygdalina (del.) leaf. World J Pharm, 7(7), 9-17.

Ugbogu, E. A., Emmanuel, O., Dike, E. D., Agi, G. O., Ugbogu, O. C., Ibe, C., & Iweala, E. J. (2021). The phytochemistry, ethnobotanical, and pharmacological potentials of the medicinal plant-Vernonia amygdalina L.(bitter Leaf). Clinical Complementary Medicine and Pharmacology, 1(1), 100006.

Iwalokun, B. A., Efedede, B. U., Alabi-Sofunde, J. A., Oduala, T., Magbagbeola, O. A., & Akinwande, A. I. (2006). Hepatoprotective and antioxidant activities of Vernonia amygdalina on acetaminophen-induced hepatic damage in mice. Journal of medicinal food, 9(4), 524-530.

Adesanoye, O. A., & Farombi, E. O. (2010). Hepatoprotective effects of Vernonia amygdalina (astereaceae) in rats treated with carbon tetrachloride. Experimental and Toxicologic Pathology, 62(2), 197-206.

Cook, N. C., & Samman, S. (1996). Flavonoids—chemistry, metabolism, cardioprotective effects, and dietary sources. The Journal of nutritional biochemistry, 7(2), 66-76.

Rice-Evans, C. A., & Packer, L. (Eds.). (2003). Flavonoids in health and disease. CRC Press.

Farombi, E. O., Akanni, O. O., & Emerole, G. O. (2002). Antioxidative and scavenging activities of kolaviron in vitro. Pharm Biol, 40, 107-116.

Mathew, J., Latha, P. G., & George, V. (2004). Antioxidant flavonoids from Vitex peduncularis. J. Trop. Med. Plants, 5, 217-221.

Schuldt, E. Z., Farias, M. R., Ribeiro-do-Valle, R. M., & Ckless, K. (2004). Comparative study of radical scavenger activities of crude extract and fractions from Cuphea carthagenensis leaves. Phytomedicine, 11(6), 523-529.

Prabhakar, K. R., Veeresh, V. P., Vipan, K., Sudheer, M., Priyadarsini, K. I., Satish, R. B. S. S., & Unnikrishnan, M. K. (2006). Bioactivity-guided fractionation of Coronopus didymus: A free radical scavenging perspective. Phytomedicine, 13(8), 591-595.

Georgewill, O. A., & Georgewill, U. O. (2010). Evaluation of the anti-inflammatory activity of extract of Vernonia amygdalina. Asian Pacific Journal of Tropical Medicine, 3(2), 150-151.

Adetunji, C. O., Olaniyi, O. O., & Ogunkunle, A. T. J. (2013). Bacterial activity of crude extracts of Vernonia amygdalina on clinical isolates. Journal of Microbiology and Antimicrobials, 5(6), 60-64.

ANIBIJUWON, I., OLADEJO, B., ADETITUN, D., & KOLAWOLE, O. (2012). Antimicrobial activities of Vernonia amygdalina against oral microbes.

Asante, D. B., Henneh, I. T., Acheampong, D. O., Kyei, F., Adokoh, C. K., Ofori, E. G., ... & Ameyaw, E. O. (2019). Anti-inflammatory, anti-nociceptive and antipyretic activity of young and old leaves of Vernonia amygdalina. Biomedicine & Pharmacotherapy, 111, 1187-1203.

Fachrunisa, D., Hasibuan, P. A. Z., & Harahap, U. (2019). Cell cycle inhibition and apoptotic induction of Vernonia amygdalina Del. leaves extract on MCF-7 cell line. Open Access Macedonian Journal of Medical Sciences, 7(22), 3807.

Gresham, L. J., Ross, J., & Izevbigie, E. B. (2008). Vernonia amygdalina: anticancer activity, authentication, and adulteration detection. International Journal of Environmental Research and Public Health, 5(5), 342-348.

Hasibuan, P. A. Z., Harahap, U., Sitorus, P., & Satria, D. (2020). The anticancer activities of Vernonia amygdalina Delile. Leaves on 4T1 breast cancer cells through phosphoinositide 3-kinase (PI3K) pathway. Heliyon, 6(7).

Howard, C. B., Mcdowell, R., Feleke, K., Deer, E., Stamps, S., Thames, E., ... & Pervin, S. (2016). Chemotherapeutic vulnerability of triple-negative breast cancer cell-derived tumors to pretreatment with Vernonia amygdalina aqueous extracts. Anticancer research, 36(8), 3933-3943.

Jisaka, M., Ohigashi, H., Takegawa, K., Huffman, M. A., & Koshimizu, K. (1993). Antitumoral and antimicrobial activities of bitter sesquiterpene lactones of Vernonia amygdalina, a possible medicinal plant used by wild chimpanzees. Bioscience, Biotechnology, and Biochemistry, 57(5), 833-834.

Wong, F. C., Woo, C. C., Hsu, A., & Tan, B. K. H. (2013). The anti-cancer activities of Vernonia amygdalina extract in human breast cancer cell lines are mediated through caspase-dependent and p53-independent pathways. Plos one, 8(10), e78021.

Dumanauw, J. M., Banne, Y., & Pakaya, W. (2020, December). EFEK ANTIPIRETIK INFUS DAUN AFRIKA (Vernonia amygdalina Del.) TERHADAP TIKUS WISTAR (Rattus norvegicus). In PROSIDING Seminar Nasional Tahun 2020 ISBN: 978-623-93457-1-6 (pp. 45-48).

Tijjani, M. A., Mohammed, G. T., Alkali, Y. T., Adamu, T. B., & Abdurahaman, F. I. (2017). Phytochemical analysis, analgesic and antipyretic properties of ethanolic leaf extract of Vernonia amygdalina Del. Journal of Herbmed Pharmacology, 6(3), 95-99.

Adiukwu, P. C., Amon, A., & Nambatya, G. (2011). Pharmacognostic, antiplasmodial and antipyretic evaluation of the aqueous extract of Vernonia amygdalina leaf. International Journal of Biological and Chemical Sciences, 5(2).